natacyn

Generic: natamycin

Labeler: eyevance pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name natacyn
Generic Name natamycin
Labeler eyevance pharmaceuticals, llc
Dosage Form SUSPENSION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

natamycin 50 mg/mL

Manufacturer
Eyevance Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 71776-005
Product ID 71776-005_42db6120-d37f-9001-e063-6294a90af191
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA050514
Listing Expiration 2026-12-31
Marketing Start 2021-06-12

Pharmacologic Class

Established (EPC)
polyene antimicrobial [epc]
Chemical Structure
polyenes [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71776005
Hyphenated Format 71776-005

Supplemental Identifiers

RxCUI
204451 207100
UNII
8O0C852CPO
NUI
N0000175936 M0017172

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name natacyn (source: ndc)
Generic Name natamycin (source: ndc)
Application Number NDA050514 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • HOW SUPPLIED: NATACYN ® (natamycin ophthalmic suspension) 5% is a 15 mL fill packaged in a 15 mL amber glass bottle with a black closure. A flint glass dropper with a red plastic closure and a black rubber bulb are packaged separately in a clear plastic blister with Tyvek backing. 15 mL NDC 71776-005-15 STORAGE: Store between 2°C to 24°C (36°F-75°F). Do not freeze . Avoid exposure to light and excessive heat. Rx Only Distributed by: Eyevance Pharmceuticals, LLC Fort Worth, Texas 76134 Revised: 05/2020
  • image description image description
source: label

Packages (0)

No package records.

Ingredients (1)

natamycin (50 mg/mL)

Linked Drug Pages (1)

NATACYN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "42db6120-d37f-9001-e063-6294a90af191", "openfda": {"nui": ["N0000175936", "M0017172"], "unii": ["8O0C852CPO"], "rxcui": ["204451", "207100"], "spl_set_id": ["2818fcb8-5bac-41fb-864e-3b598308a428"], "pharm_class_cs": ["Polyenes [CS]"], "pharm_class_epc": ["Polyene Antimicrobial [EPC]"], "manufacturer_name": ["Eyevance Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "NATACYN", "product_id": "71776-005_42db6120-d37f-9001-e063-6294a90af191", "dosage_form": "SUSPENSION/ DROPS", "pharm_class": ["Polyene Antimicrobial [EPC]", "Polyenes [CS]"], "product_ndc": "71776-005", "generic_name": "natamycin", "labeler_name": "Eyevance Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NATACYN", "active_ingredients": [{"name": "NATAMYCIN", "strength": "50 mg/mL"}], "application_number": "NDA050514", "marketing_category": "NDA", "marketing_start_date": "20210612", "listing_expiration_date": "20261231"}